PITTSBURGH and LONDON, Dec. 4, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Laboratories Limited has received tentative approval from the U.S. Food and Drug ...

PITTSBURGH and BANGALORE, India, September 6, 2023 /CSRwire/ - Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced U.S. Food and Drug Administration (FDA) tentative approval for ...

Researchers at the University of Colorado Anschutz Medical Campus have helped confirm the dosing, safety and effectiveness of a drug formulation designed for treating children with human ...

Follows recent agreement with ViiV Healthcare in collaboration with Clinton Health Access Initiative to expand reach of pediatric formulation of Abacavir/Lamivudine to resource-limited settings Mylan ...

Study, which was published in The Lancet HIV, found that combining 3 medications in a single fixed dose combination is effective for treating children with HIV. Researchers at the University of ...

New child-friendly formulations of several important antiretroviral medicines were recently approved by the South African Health Products Regulatory Authority. Thabo Molelekwa asks what this means for ...

Advancements in soft capsule technology can enable the development of soft capsule formulations, which are becoming the preferred method of oral administration. Soft capsule formulation technology ...

Chicago, Sept. 16, 2003 – An unplanned interim analysis of a study comparing tenofovir disoproxil fumarate (TDF) to efavirenz (EFV) - both given in combination with a fixed-dose investigational ...

The fixed-dose combination of abacavir 60 mg/dolutegravir 5 mg/lamivudine 30 mg tablets for oral suspension is indicated for the treatment of HIV-1 infection in paediatric patients weighing at least 6 ...